(Q43562015)

24 November 2017

Human kallikrein 10: a novel tumor marker for ovarian carcinoma? (English)

1 reference

24 November 2017

3

1 reference

PubMed ID

11282101

24 November 2017

Eleftherios P. Diamandis

series ordinal

4

1 reference

24 November 2017

Luo LY

1

1 reference

PubMed ID

11282101

24 November 2017

Bunting P

series ordinal

2

1 reference

24 November 2017

1 April 2001

1 reference

24 November 2017

1 reference

24 November 2017

306

1 reference

24 November 2017

111-118

1 reference

24 November 2017

1-2

1 reference

Characterization of the human kallikrein locus

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900401-6

Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900401-6

Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900401-6

The new human kallikrein gene family: implications in carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900401-6

Structural characterization and mapping of the normal epithelial cell-specific 1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900401-6

Prostate-specific antigen and early detection of prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900401-6

Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900401-6

Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900401-6

CA 125: the past and the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900401-6

Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900401-6

Is inhibin a serum marker for ovarian cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900401-6

Inhibin and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900401-6

OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900401-6

10.1016/S0009-8981(01)00401-6

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference

PubMed ID

11282101